Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthonius de Boer

Showing results (31-40 of 308) with videos related to

Pageof 31
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|April 26, 2013
[Ethnicity in pharmacogenetics]Timothy A A Sontoredjo, Anthonius de Boer, Anke H Maitland-van der Zee
British Journal of Clinical Pharmacology|November 23, 2019
Medication safety in patients with hepatic impairment: A survey of community pharmacists' knowledge level and their practice in caring for these patientsRianne A Weersink, Marianna Abadier, Anthonius de Boer, et al.
Journal of Clinical Epidemiology|July 17, 2018
Using a single noninferiority margin or preserved fraction for an entire pharmacological class was found to be inappropriateTurki A Althunian, Anthonius de Boer, Rolf H H Groenwold, et al.
Journal of Hypertension|October 7, 2005
Rate and determinants of 10-year persistence with antihypertensive drugsBoris Lg Van Wijk, Olaf H Klungel, Eibert R Heerdink, et al.
Pharmacoepidemiology and Drug Safety|May 13, 2020
Quality of reporting of drug exposure in pharmacoepidemiological studiesMirjam Hempenius, Kim Luijken, Anthonius de Boer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 15, 2017
Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA AgenciesAmr Makady, Renske Ten Ham, Anthonius de Boer, et al.
Pharmacoepidemiology and Drug Safety|August 3, 2019
Amiodarone use and the risk of acute pancreatitis: Influence of different exposure definitionsMirjam Hempenius, Rolf H H Groenwold, Anthonius de Boer, et al.
Journal of Hypertension|August 18, 2004
The association between compliance with antihypertensive drugs and modification of antihypertensive drug regimenBoris L G Van Wijk, Olaf H Klungel, Eibert R Heerdink, et al.
Pharmacoepidemiology and Drug Safety|April 6, 2006
Initial non-compliance with antihypertensive monotherapy is followed by complete discontinuation of antihypertensive therapyBoris L G Van Wijk, Olaf H Klungel, Eibert R Heerdink, et al.
The Annals of Pharmacotherapy|November 24, 2005
Generic substitution of antihypertensive drugs: does it affect adherence?Boris L G Van Wijk, Olaf H Klungel, Eibert R Heerdink, et al.
Pageof 31

Showing results (31-40 of 308) with videos related to

Sort By:
Pageof 31
Nederlands Tijdschrift Voor Geneeskunde|April 26, 2013
[Ethnicity in pharmacogenetics]Timothy A A Sontoredjo, Anthonius de Boer, Anke H Maitland-van der Zee
British Journal of Clinical Pharmacology|November 23, 2019
Medication safety in patients with hepatic impairment: A survey of community pharmacists' knowledge level and their practice in caring for these patientsRianne A Weersink, Marianna Abadier, Anthonius de Boer, et al.
Journal of Clinical Epidemiology|July 17, 2018
Using a single noninferiority margin or preserved fraction for an entire pharmacological class was found to be inappropriateTurki A Althunian, Anthonius de Boer, Rolf H H Groenwold, et al.
Journal of Hypertension|October 7, 2005
Rate and determinants of 10-year persistence with antihypertensive drugsBoris Lg Van Wijk, Olaf H Klungel, Eibert R Heerdink, et al.
Pharmacoepidemiology and Drug Safety|May 13, 2020
Quality of reporting of drug exposure in pharmacoepidemiological studiesMirjam Hempenius, Kim Luijken, Anthonius de Boer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 15, 2017
Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA AgenciesAmr Makady, Renske Ten Ham, Anthonius de Boer, et al.
Pharmacoepidemiology and Drug Safety|August 3, 2019
Amiodarone use and the risk of acute pancreatitis: Influence of different exposure definitionsMirjam Hempenius, Rolf H H Groenwold, Anthonius de Boer, et al.
Journal of Hypertension|August 18, 2004
The association between compliance with antihypertensive drugs and modification of antihypertensive drug regimenBoris L G Van Wijk, Olaf H Klungel, Eibert R Heerdink, et al.
Pharmacoepidemiology and Drug Safety|April 6, 2006
Initial non-compliance with antihypertensive monotherapy is followed by complete discontinuation of antihypertensive therapyBoris L G Van Wijk, Olaf H Klungel, Eibert R Heerdink, et al.
The Annals of Pharmacotherapy|November 24, 2005
Generic substitution of antihypertensive drugs: does it affect adherence?Boris L G Van Wijk, Olaf H Klungel, Eibert R Heerdink, et al.
Pageof 31